PB1862: BRUIN CLL-313: A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF PIRTOBRUTINIB VS BENDAMUSTINE+RITUXIMAB IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (TRIAL IN PROGRESS)

Detalles Bibliográficos
Autores principales: Jurczak, W., Dartigeas, C., Coscia, M., Ganly, P., Al-Jazayrly, G., Wang, C., Bao, K., Leow, C. C., Shahda, S., Zinzani, P. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431638/
http://dx.doi.org/10.1097/01.HS9.0000850300.53785.f4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431638/
http://dx.doi.org/10.1097/01.HS9.0000850300.53785.f4

Ejemplares similares